<http://webisa.webdatacommons.org/prov/447829315>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/50112611> .
<http://webisa.webdatacommons.org/prov/229325292>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/50112611> .
<http://webisa.webdatacommons.org/50112611>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/50112611>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/50112611>	<http://www.w3.org/ns/prov#value>	"As used herein, ???5??-stanol absorption inhibitor??? means a compound capable of inhibiting the absorption of one or more 5??-stanols (such as cholestanol, 5??-campestanol, 5??-sitostanol), when administered in a therapeutically effective (5??-stanol absorption inhibiting) amount to a subject, such as a mammal or human." .